Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Bioporto A/S

BIOPOR.CO ✓ COMPLIANT ☆ Track — members

Nasdaq Copenhagen · Healthcare · Medical Equipment, Supplies & Distribution ·

Denmark Micro Cap Analyst: N/A

Last Close

$0.19

▼ -5.88%

Market Cap $92.84M · Vol 213.15K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$92.84M

Micro Cap

Div Yield

0.00%

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

53.52

Momentum

Beta

0.89

vs Market

52W High

$0.23

19.37% below

52W Low

$0.13

45.32% above

Volume

213.15K

Avg 324.13K

P/B

8.01

Price-to-book

ROE

N/A

Return on equity

Free Float

70.20%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Bioporto A/S (BIOPOR.CO) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BIOPOR.CO pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.42%

+2.13%

-3.61%

+25.13%

YTD

+17.65%

-7.69%

-13.82%

-59.82%

Financials & Valuation

TTM · Annual

Total Revenue	$6.34M
Net Income	$-12,914,118.00
Revenue Growth (YoY)	-34.83%
Gross Margin	75.44%
Operating Margin	-213.70%
Net Profit Margin	-203.83%
ROE	N/A
ROA · ROIC	-92.64% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	12.54
P/B	8.01
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	495.11M

Technical Indicators

50-Day SMA	$0.18
200-Day SMA	$0.17
RSI (14)	53.52
Beta	0.89
52-Week High	$0.23
52-Week Low	$0.13

Volume Today	213.15K
Avg Daily Volume (30D)	324.13K
Relative Volume	0.66x
Volatility (10D)	46.32
Volatility (30D)	50.96
Free Float	70.20%

Analyst Consensus

N/A

Current Price $0.19

Mean Target $0.27

52W Low$0.13 52W High$0.23

Current

Target

$0.13 $0.23

Current Analyst target

+46.34% upside potential · 1 analysts

Identifiers

ExchangeNasdaq Copenhagen

FIGIBBG001SB4RF2

ISINDK0011048619

CountryDenmark

Sub-IndustryLaboratory Diagnostic & Testing Substances

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

GH Guardant Health Inc -4.40% BIM.PA Biomerieux SA -0.20% TXG 10X Genomics Inc -2.03% CAI Caris Life Sciences Inc -0.53% LNTH Lantheus Holdings Inc +0.83%

Company Profile

Bioporto A/S is a Denmark-based company engaged in the development and marketing of in vitro diagnostic (IVD) assays. The Company’s portfolio comprises five product categories: The Neutrophil gelatinase-associated lipocalin (NGAL) Test, which is a test for diagnosing acute kidney injury; NGAL Enzyme-linked immunosorbent assay (ELISA) kits, which supplies NGAL for the development of medicines for estimating side-effects that are harmful to kidneys; Mannan-binding Lectin (MBL) ELISA kit, which offers monoclonal MBL antibodies that are responsible for the activation of immune response; Antibodies, including monoclonal antibodies used in a range of research areas, such as microbiology, biomarkers, peptide hormones and plasma proteins; and Activated Protein C with Protein C Inhibitor Complex (APC-PCI), a biomarker applied to patients with sepsis and thrombotic and hemostatic disorders. In addition, the Company is a parent of BioPorto Diagnostics A/S.